NCT02838784View on ClinicalTrials.gov

Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers

NAUnknownINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Venous UlcerFoot Ulcer, Diabetic
Interventions
OTHER

Artacent Human Amniotic Membrane

Double layer dehydrated amnion product

PROCEDURE

Standard of Care

Off loading with a cast walker, non-adherent dressings, debridement and moisture retentive dressings

Trial Locations (7)

11710

RECRUITING

Livingston Podiatry Associates PLLC, Bellmore

43123

RECRUITING

Foot & Ankle Physicians of Ohio, Grove City

68114

COMPLETED

Foot & Ankle Center of Nebraska, Omaha

70121

RECRUITING

Ochsner Clinic Foundation, New Orleans

70560

RECRUITING

Iberia Medical Center, New Iberia

78735

RECRUITING

Southwest Austin Foot & Ankle Clinic, PLLC, Austin

91007

RECRUITING

Global Podiatry Partners, Inc, Arcadia

Sponsors

Lead Sponsor

Tides Medical
All Listed Sponsors
lead

Tides Medical

INDUSTRY

NCT02838784 - Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers | Biotech Hunter | Biotech Hunter